Arizona sued L'Oreal for hiding cancer risks in hair relaxers. The state says the company broke consumer protection laws. Many users already filed their own lawsuits. L'Oreal apparently ran the numbers and decided legal fees beat warning labels.
This joins the long tradition of corporations asking themselves "What if we just don't tell them?" and then acting shocked when regulators show up. The risk-reward calculation must have looked great in a conference room somewhere. Sell the product now. Deal with the class action later. Maybe the lawyers cost less than the lost revenue. Maybe everyone just forgets about the cancer thing.
They did not forget about the cancer thing.
Arizona's attorney general now wants damages and injunctions. The state argues L'Oreal marketed these products knowing the risks. Knowing. Past tense. Which means someone at L'Oreal read a report that said "Hey this might cause cancer" and filed it under "Problems for 2026 L'Oreal." That person probably got a bonus.
The technical analysis here is bulletproof. If you bought L'Oreal stock thinking "Finally, a company that sells carcinogens without disclosure," congratulations on your thesis playing out exactly as planned. If you bought it for literally any other reason, you now own shares in a business model that includes "Get sued by Arizona and also everyone who used the product." The chart patterns cannot save you. The 200-day moving average does not care about your feelings. The Fibonacci retracement will not testify on your behalf.
Retail traders will still buy the dip. They always do. Some guy named Derek is already typing "L'Oreal oversold, cancer risks priced in" into his Discord. Derek has never read a 10-K. Derek does not know what a 10-K is. Derek will lose money and blame market manipulation. Derek's hairline is fine because he would never use a product marketed to someone other than Derek.
Photo by Toa Heftiba on Unsplash
Leave a Comment